European experience: Biosimilar infliximab works as well as Remicade for IBD

SAN DIEGO – Biosimilar infliximab (Inflectra) was as safe and effective as the original version (Remicade) in an Italian observational cohort study of 547 inflammatory bowel disease (IBD) patients,...
Source: Family Practice News - Category: Primary Care Source Type: news